Gene Therapy Using Xenogeneic Cells in Cancer Treatment
Author Information
Author(s): Tartour E, Mehtali M, Sastre-Garau X, Joyeux I, Mathiot C, Pleau J M, Squiban P, Rochlitz C, Courtney M, Jantscheff P, Herrmann R, Pouillart P, Fridman W H, Dorval T
Primary Institution: Institut Curie, Université Pierre et Marie Curie, Paris, France
Hypothesis
Can gene therapy using xenogeneic cells effectively treat metastatic solid tumors without severe adverse effects?
Conclusion
The trial showed no severe adverse effects from the treatment, suggesting that gene therapy with xenogeneic cells may be safe and potentially effective.
Supporting Evidence
- No severe adverse effects were observed in the 8 patients.
- Exogenous IL-2 mRNA was undetectable in blood 48 hours after treatment.
- Histological responses were noted in treated nodules despite no apparent clinical response.
Takeaway
Doctors tested a new treatment for cancer using special cells that help the body fight tumors, and it didn't make the patients sick.
Methodology
The study involved administering genetically engineered monkey fibroblasts producing human IL-2 to patients with metastatic solid tumors.
Limitations
The study had a small sample size and did not assess long-term effects.
Participant Demographics
Patients with metastatic solid tumors.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website